Trial
NCT04823624
MBG453 in Lower Risk MDS
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
Novartis
Condition
Myelodysplastic Syndromes
Intervention
MBG453
Why stopped
The trial closed early due to changes in support for the study drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-27